Rainbow BioSciences, LLC's Pending JV Partner Amarantus Therapeutics Licenses Alzheimer's Blood Test Breakthrough
12/19/2012 9:31:49 AM
More...
|
Amarantus Therapeutics Obtains European Patent Notice of Allowance Covering Discovery of Lead Protein MANF
7/28/2010 9:55:17 AM
More...
|
Amarantus Therapeutics Announces Appointment of Lawrence M. Schwartz, Ph.D., to Scientific Advisory Board
6/16/2010 11:33:26 AM
More...
|
Amarantus Therapeutics Appoints Dr. Robert J. Zimmerman as Chief Development Officer
5/24/2010 11:29:59 AM
More...
|
Michael J. Fox Foundation for Parkinson's Research Awards Grant to Amarantus Therapeutics
4/28/2010 11:18:36 AM
More...
|
Amarantus Therapeutics to Present at the OneMedForum 2010 Conference
1/7/2010 11:05:26 AM
More...
|
CNS Protein Therapeutics Completes Name Change to Amarantus Therapeutics, Appoints New CEO Martin D. Cleary
10/28/2009 10:22:36 AM
More...
|